Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04041167
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT04041167
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04041167. Randomized; no masking; primary purpose treatment. Start 2018-08-01 (actual); primary completion 2021-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- alpha lipoic acid
- Intervention (Drug)
- Saline
- Lead sponsor
- Chonnam National University Hospital
- Collaborator
- Chosun University Hospital
- Collaborator
- Chonbuk National University Hospital
- Collaborator
- Wonkwang University Hospital
Record details
- Record id
cardio:ct-nct04041167- Content hash
a39e19e0f14e0b7bc9a665905a3920880e81d55397b6a0eb19e1f0a40e38d733